Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stockwatch: biotech stocks propped by dubious market research

This article was originally published in Scrip

Executive Summary

This is the time of year when I supervise MPhil students from the University of Cambridge who are researching and writing their dissertations. At this level, students should be able to demonstrate some quantitative analysis. In an assignment that only lasts a few months, that usually means that they conduct some primary market research. Thankfully, students can learn from my mistakes: I never want them to have that nauseous feeling you get when you read the results of a $30,000 market research study and realize that you did not have the most commercially important question in the questionnaire.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028737

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel